Messner & Smith Theme Value Investment Management’s Cardiff Oncology CRDF Stock Holding History

Messner & Smith Theme Value Investment Management’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$8K	Sell	317 -14	-4%	-$345	0.01%	81
2017 Q4	$7K	Sell	331 -43	-11%	-$1.9K	0.01%	76
2017 Q3	$20K	Hold	374	–	–	0.03%	71
2017 Q2	$34K	Hold	374	–	–	0.06%	70
2017 Q1	$31K	Sell	374 -99	-21%	-$13.4K	0.05%	70
2016 Q4	$72K	Sell	473 -28	-6%	-$6.54K	0.12%	68
2016 Q3	$162K	Hold	501	–	–	0.26%	68
2016 Q2	$163K	Sell	501 -21	-4%	-$7.23K	0.3%	59
2016 Q1	$175K	Buy	522 +16	+3%	+$5.44K	0.34%	58
2015 Q4	$197K	Sell	506 -27	-5%	-$10.6K	0.32%	61
2015 Q3	$218K	Hold	533	–	–	0.43%	50
2015 Q2	$390K	Sell	533 -15	-3%	-$10.6K	0.54%	45
2015 Q1	$269K	Buy	+548	New	+$234K	0.38%	55

Other funds holding CRDF

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Messner & Smith Theme Value Investment Management's CRDF Position: Q1 2018 in Review

Messner & Smith Theme Value Investment Management reduced its Cardiff Oncology (CRDF) stake by 4.2% in Q1 2018, selling an estimated $345 and leaving 317 shares worth $8K. The position accounts for 0.01% of the portfolio, ranked #81.

Messner & Smith Theme Value Investment Management first reported a position in CRDF in Q1 2015 and has held it in 13 quarters since. The position peaked at $390K in Q2 2015. 37 funds tracked by Wall St. Rank hold CRDF as of Q1 2018.

Messner & Smith Theme Value Investment Management held 317 shares of Cardiff Oncology worth $8K as of Q1 2018.
Messner & Smith Theme Value Investment Management sold 14 Cardiff Oncology shares in Q1 2018, an estimated $345.
Cardiff Oncology made up 0.01% of Messner & Smith Theme Value Investment Management's portfolio in Q1 2018, its #81 holding.
Messner & Smith Theme Value Investment Management first reported a position in Cardiff Oncology in Q1 2015 and has held it in 13 quarters since.
Messner & Smith Theme Value Investment Management's Cardiff Oncology position peaked at $390K in Q2 2015.
37 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2018.

Based on Messner & Smith Theme Value Investment Management's 13F filing for Q1 2018, filed 9 May 2018.